Riverview Trust Co Sells 288 Shares of Oracle Corporation $ORCL

Riverview Trust Co trimmed its position in shares of Oracle Corporation (NYSE:ORCL) by 21.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,082 shares of the enterprise software provider’s stock after selling 288 shares during the quarter. Riverview Trust Co’s holdings in Oracle were worth $237,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ORCL. Reyes Financial Architecture Inc. raised its holdings in shares of Oracle by 7.2% during the 2nd quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after acquiring an additional 43 shares during the period. Davis Investment Partners LLC raised its holdings in shares of Oracle by 0.7% during the 2nd quarter. Davis Investment Partners LLC now owns 6,930 shares of the enterprise software provider’s stock worth $1,517,000 after acquiring an additional 46 shares during the period. Acropolis Investment Management LLC raised its holdings in shares of Oracle by 2.6% during the 2nd quarter. Acropolis Investment Management LLC now owns 1,850 shares of the enterprise software provider’s stock worth $404,000 after acquiring an additional 47 shares during the period. Sunpointe LLC raised its holdings in shares of Oracle by 0.9% during the 2nd quarter. Sunpointe LLC now owns 5,563 shares of the enterprise software provider’s stock worth $1,216,000 after acquiring an additional 48 shares during the period. Finally, American Financial Advisors LLC raised its holdings in Oracle by 2.3% in the 2nd quarter. American Financial Advisors LLC now owns 2,234 shares of the enterprise software provider’s stock valued at $488,000 after buying an additional 50 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Oracle

In other news, insider Michael D. Sicilia sold 33,845 shares of the business’s stock in a transaction dated Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider directly owned 132,656 shares of the company’s stock, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Rona Alison Fairhead acquired 480 shares of the stock in a transaction dated Monday, July 7th. The shares were bought at an average cost of $233.87 per share, with a total value of $112,257.60. Following the completion of the transaction, the director owned 22,110 shares of the company’s stock, valued at approximately $5,170,865.70. This represents a 2.22% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 104,314 shares of company stock valued at $31,272,223. 42.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ORCL shares. Cowen restated a “buy” rating and issued a $375.00 price objective on shares of Oracle in a report on Wednesday, September 10th. BMO Capital Markets set a $345.00 price objective on shares of Oracle in a report on Wednesday, September 10th. Wolfe Research boosted their price objective on shares of Oracle from $300.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, September 10th. Roth Capital restated a “hold” rating on shares of Oracle in a report on Wednesday, June 18th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Oracle from $185.00 to $210.00 and gave the company a “neutral” rating in a report on Monday, September 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $304.71.

Oracle Stock Performance

NYSE ORCL opened at $289.68 on Thursday. The company has a market cap of $825.83 billion, a P/E ratio of 67.06, a P/E/G ratio of 3.03 and a beta of 1.53. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The stock has a 50-day moving average of $260.78 and a two-hundred day moving average of $203.24. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72.

Oracle (NYSE:ORCL) last released its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business’s revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. Oracle’s payout ratio is currently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.